TXG
10x Genomics Inc.
Company Overview
| Mkt Cap | $1.62B | Price | $13.61 |
| Volume | 1.24M | Change | -0.26% |
| P/E Ratio | -8.9 | Open | $13.67 |
| Revenue | $610.8M | Prev Close | $13.64 |
| Net Income | $-182.6M | 52W Range | $6.78 - $18.21 |
| Div Yield | N/A | Target | $14.86 |
| Overall | 64 | Value | 60 |
| Quality | 60 | Technical | 72 |
No chart data available
Stock Overview
Updated Daily10x Genomics Inc. (TXG) is a leading Health Information Services company in the Healthcare industry, currently trading at $13.61 with a market capitalization of $1.62 billion. The stock is trading in the middle of its 52-week range, demonstrating solid quality metrics with a MarketXLS quality score of 60.
Today's trading session shows TXG with a volume of 1.24 million shares. The stock opened up 0.22% from yesterday's close of $13.64. Current analyst estimates project earnings of $-0.87 per share for this year, with next year targeting $-0.86.
TXG demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MYMX, MRVI, NBIX, NSTG.
Key investment considerations for TXG include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 9.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TXG | $13.61 | -0.3% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |